Shopping Cart
Evidence update · July 2026
PRP penile injection
PRP penile injections for erectile dysfunction: procedure, evidence and risks
Intracavernosal PRP injections are being studied as a regenerative approach to erectile dysfunction. The biological rationale is plausible, but a reliable clinical benefit has not yet been demonstrated.
Not an established standardInconsistent evidenceMedical assessment required
The key point first
Recent meta-analyses of randomised trials found no consistent, clinically convincing advantage over placebo. The EAU therefore continues to restrict intracavernosal PRP injections to clinical-trial settings.
01 · Basics
What does PRP penile injection mean?
The procedure involves preparing platelet-rich plasma from the patient’s own blood and injecting it into the erectile tissue. Research has mainly focused on men with mild to moderate erectile dysfunction of predominantly organic or vascular origin.
It should not be presented as a general “potency treatment”. Current studies do not support reliable claims about penile enlargement, increased sensitivity, orgasmic function or a broad improvement in sexual performance.
02 · Assessment
Why diagnosis comes before treatment
Erectile dysfunction is a symptom with many possible causes, including vascular and metabolic disease, hormonal or neurological factors, medication, psychological distress and mixed causes. New symptoms can also be an early sign of previously unrecognised cardiovascular risk.
Depending on the case, urological or andrological assessment may include medical and sexual history, physical examination and metabolic, lipid and hormone tests. Prescription medicines—especially anticoagulants—must never be stopped or changed without the treating physician’s approval.
1
Vascular health
Blood flow, blood pressure, diabetes and lipid disorders can affect erectile function.
2
Hormones and nerves
Low testosterone, neurological disease or pelvic surgery may contribute.
3
Psychological and relationship factors
Stress, anxiety, depression and relationship difficulties can trigger or aggravate symptoms.
03 · Biology
What is PRP, and what mechanism is proposed?
PRP is plasma with a higher platelet concentration than the starting sample. Platelets release signalling molecules and growth factors. Preclinical research explores possible effects on blood vessels, endothelium, nerve structures and local repair processes.
That is a biological hypothesis, not proof of clinical efficacy. It remains unclear whether these processes produce a relevant and lasting improvement in erectile function in humans.
04 · Workflow
How the procedure is broadly performed in studies
1
Blood collection
A defined volume of blood is collected under sterile conditions.
2
PRP preparation
The blood is centrifuged with an appropriate system. PRP composition and concentration vary between methods.
3
Physician-administered injection
A suitably qualified physician injects the preparation intracavernosally and provides follow-up.
There is no generally accepted standard protocol. Studies differ in PRP volume, preparation, activation, number of sessions and follow-up.
05 · Evidence
What do clinical studies show?
Biological rationale ≠ clinical proofPRP penile injection · 2026
Some earlier small studies reported improvements in questionnaire scores such as IIEF-EF. More recent analyses including additional randomised trials are considerably more cautious.
1
7 RCTs · 512 participants
A 2026 meta-analysis found no consistent, clinically meaningful advantage of PRP monotherapy over placebo at one, three or six months. Heterogeneity between trials was high.
2
7 RCTs · 479 participants
A second analysis found no advantage in pooled IIEF scores at the three follow-up points. One six-month responder result was based on only three studies and requires caution.
3
Why results differ
Patient selection, PRP composition, injection volume, treatment schedules and outcomes are not standardised. Small samples and short follow-up limit confidence.
| Current state of knowledge | Assessment |
|---|---|
| Are there randomised trials? | Yes, but patient numbers are limited and protocols differ. |
| Is efficacy established? | No. The latest meta-analyses do not show a stable advantage over placebo. |
| Is there a standard protocol? | No. Preparation, dose, injection technique and session count vary. |
| Is PRP standard care for ED? | No. It is not established as routine guideline-supported treatment. |
| Is long-term safety known? | Not adequately. Larger studies with longer follow-up are missing. |
06 · Guideline
What does the EAU guideline say?
EAU
The European Association of Urology notes potentially positive signals but considers the evidence insufficient. Its current guidance limits intracavernosal PRP injections to clinical trials. This carries more weight than individual testimonials or isolated small studies.
07 · Safety
Potential risks and unanswered questions
Pain, pressure or temporary swelling
Bruising, bleeding and injection-site reactions
Infection despite the use of autologous material
Induration or plaque formation, reported only occasionally in trials
No treatment effect and additional costs
Uncertain long-term effects due to limited follow-up
“Autologous” does not mean “risk-free”. The material comes from the patient’s blood, but blood collection, processing and injection remain medical procedures. Hygiene, device selection, centrifugation and injection technique all affect safety.
08 · Care
Which established options are available?
Treatment depends on cause, severity, comorbidities and patient preference. Guideline-supported options may include risk-factor modification, PDE5 inhibitors, vacuum erection devices, intraurethral or intracavernosal alprostadil, psychosexual support and surgery when indicated. PRP is not currently on the same evidence level.
09 · B2B
Technical PRP preparation for healthcare professionals
The following links provide general product information for professional PRP preparation. They are not a recommendation for PRP penile injection, not evidence of treatment efficacy and not confirmation that the products are suitable for this indication. Intended purpose, instructions for use, internal SOPs and the physician’s decision remain decisive.
Vi PRP-PRO PRP tubes
Technical product data, additives, CE status and standard centrifugation information.
View PRP tubesHettich EBA 200 MD
Product information on the medical-device centrifuge for practices, laboratories and clinics.
View centrifuge10 · FAQ
Frequently asked questions about PRP penile injection
Is PRP penile injection scientifically proven?
No. Clinical studies exist, but the results are inconsistent. The latest meta-analyses do not show a consistent advantage over placebo.
Is the procedure free of side effects?
No. Autologous blood reduces some immunological risks, but an invasive injection is not risk-free.
How many sessions are needed?
There is no generally accepted standard. Studies used different volumes and treatment schedules.
How long might an effect last?
There is no reliable general answer. Follow-up in the available studies is limited.
Can PRP permanently enlarge the penis?
There is no robust clinical evidence that PRP produces reliable permanent penile enlargement.
Can I stop blood thinners before the procedure?
Not on your own. Any change to prescribed medication must be agreed with the treating physician.
A balanced conclusion
PRP injections into erectile tissue remain an investigational approach. The mechanisms are plausible, but clinical benefit has not been reliably established. Men with erectile difficulties should first have a qualified urological or andrological assessment and discuss established treatment options.